C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2002
11/19/2002	US6482928 Fab′-epitope complex from HIV-1 cross-neutralizing monoclonal antibody 2F5
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002	US6482924 Leptospira vaccine antigens for the prevention of Leptospirosis
11/19/2002	US6482922 Mammary transforming protein
11/19/2002	US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002	US6482630 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482614 Stress proteins and uses therefor
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482607 Expression vector for use in a one-step purification protocol
11/19/2002	US6482603 Method of detecting drug-receptor and protein-protein interactions
11/19/2002	US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002	US6482412 Actinomyces used to biosynthesize polypeptide to treat aids
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2153546C Periwinkle grain extract and composition containing the same
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA1341400C Process for preparing proteins
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/19/2002	CA1341398C Expression of biologically active pdgf analogs in eucaryotic cells
11/14/2002	WO2002092769A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	WO2002090570A2 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090537A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	WO2002090533A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090529A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090300A2 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002081694A8 Method for the sectetion and production of protein
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002	WO2002066628A3 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	WO2002046455A3 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
11/14/2002	WO2002016440A8 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
11/14/2002	WO2001021636A9 Identification of a vaccine candidate from an extraintestinal isolate of e. coli
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders
11/14/2002	US20020169286 Peptide for use in the detection and prevention of epstein barr infections
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169118 TNF receptors, TNF binding proteins and DNAs coding for them
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169106 Administering an OB-cadherin CAR (cell adhesion recognition) sequence
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168728 Generation preferential proteins; obtain gram-negative prokaryotic cell, transform with nucleotide sequences coding protein, culture, recover protein
11/14/2002	US20020168726 Bacterial antigens and vaccine compositions
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168712 Molecules designated LDCAM
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168706 Improved in vitro synthesis system
11/14/2002	US20020168705 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
11/14/2002	US20020168704 Method for producing a protein hydrolysate with low bitterness
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168684 Generating preferential immunoglobulins; obtain peptide library, immunize cells, isolate anitgen, purify immunoglobulin
11/14/2002	US20020168675 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168662 Sperm protein 17 for the diagnosis and treatment of cancer
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168392 Antimicrobial proteins
11/14/2002	US20020168381 Mixture of bone protein and ethylene oxide-propylene oxide copolymer; in situ administering
11/14/2002	US20020168379 Veterinary medicine; swine respiratory system disorders
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168363 Integrin/adhesion antagonists
11/14/2002	US20020168362 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/14/2002	CA2447407A1 Nucleic acids and proteins with thioredoxin reductase activity
11/14/2002	CA2447386A1 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446819A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446394A1 Insulinotropic peptide derivatives
11/14/2002	CA2446031A1 Process for synthesizing protein using cell-free protein synthesis system
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256804A1 HBcAg expression and diagnostic and therapeutic uses
11/13/2002	EP1256352A2 Immunomodulatory peptides
11/13/2002	EP1255869A1 Nucleic acids, proteins, and antibodies

1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 1125